President-elect Donald Trump interviewed what appear to be two unconventional candidates for FDA commissioner, but at least one other potential selection remains among those that could receive the nomination.
The transition team indicated that Trump met with Jim O'Neill, managing director of Mithril Capital Management, and Balaji Srinivasan, partner at Andreessen Horowitz and CEO of 21.co, on Jan. 12 at Trump Tower in New York
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?